L550-0771 Screening compound: 1-cyclohexyl-4-(3-{2-[3-(4-fluorophenyl)-1,2,4-oxadiazol-5-yl]ethyl}-[1,2,4]triazolo[4,3-b]pyridazin-6-yl)piperazine

L550-0771 Screening compound: 1-cyclohexyl-4-(3-{2-[3-(4-fluorophenyl)-1,2,4-oxadiazol-5-yl]ethyl}-[1,2,4]triazolo[4,3-b]pyridazin-6-yl)piperazine
L550-0771 Screening compound: 1-cyclohexyl-4-(3-{2-[3-(4-fluorophenyl)-1,2,4-oxadiazol-5-yl]ethyl}-[1,2,4]triazolo[4,3-b]pyridazin-6-yl)piperazine alternative view

Chemical Structure Depiction of ChemDiv screening compound L550-0771
1-cyclohexyl-4-(3-{2-[3-(4-fluorophenyl)-1,2,4-oxadiazol-5-yl]ethyl}-[1,2,4]triazolo[4,3-b]pyridazin-6-yl)piperazine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L550-0771

Molecular Formula

C25H29FN8O (C25 H29 FN8 O)

Compound Name

1-cyclohexyl-4-(3-{2-[3-(4-fluorophenyl)-1,2,4-oxadiazol-5-yl]ethyl}-[1,2,4]triazolo[4,3-b]pyridazin-6-yl)piperazine

IUPAC name

1-cyclohexyl-4-(3-{2-[3-(4-fluorophenyl)-124-oxadiazol-5-yl]ethyl}-[124]triazolo[43-b]pyridazin-6-yl)piperazine

SMILES

Fc(cc1)ccc1-c1noc(CCc2nnc(cc3)n2nc3N(CC2)CCN2C2CCCCC2)n1

InChI

InChI=1S/C25H29FN8O/c26-19-8-6-18(7-9-19)25-27-24(35-31-25)13-12-22-29-28-21-10-11-23(30-34(21)22)33-16-14-32(15-17-33)20-4-2-1-3-5-20/h6-11,20H,1-5,12-17H2

InChI Key

KFMXKZJMWBPRDC-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27461157

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

476.56

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

4.509

Distribution Coefficient, logD

3.854

Water Solubility, LogSw

-4.38

Polar Surface Area

70.726

Acid Dissociation Constant (pKa)

23.62

Base Dissociation Constant (pKb)

7.95

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

48.00

L550-0771 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

GPCR Targeted Library (31838 compounds)

SmartTM Library (51161 compounds)

Targeted Diversity Library (40567 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with L550-0771 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L550-0771?
Check Price and Availability of L550-0771, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L550-0771 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L550-0771
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L550-0771
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L550-0771 available by request